Residents of the ancient city of Ibadan and well-wishers from across the country and beyond roll out the drums to honour Samuel Osundiran Odulana, the Olubadan of Ibadan, as he marks his 100th birthday If many are asked who was the one Nigerian born in 1914, the year of the country’s amalgamation, who fought in…
Enter the World’s First Malaria Vaccine
All things being equal, the world’s first malaria vaccine could make its debut in 2015. GlaxoSmithkline, GSK, the pharmaceutical company behind the vaccine development, has indicated that if the gains from RTS,S – the name of the vaccine – continue then it would apply for a licence from the European Medicines Agency. In spite…
Why Lagos Hospitals Need Surgery
A combination of negligence, dearth of bed spaces and acute staff shortage in the face of overwhelming patient traffic tops the list of factors militating against the efforts of Lagos State government to deliver quality health care to the citizenr She waited seven years and nine months for the birth of her second child. Supported…
Waging War Against Counterfeit Drugs
It seems that the Society for Family Health, SFH, may have finally found a way to beat drug counterfeiters. Recently, the organisation unveiled the mobile authentication service, MAS, coding for Postinor 2, an emergency contraceptive pill, in Lagos. With the launch, it was revealed that people can now buy Postinor 2 from a pharmacy, scratch…
United Against Breast Cancer
It was not a first attempt, but Skye Bank has dealt breast cancer a major blow. Recently, the bank donated two ultra modern screening machines to Care Organisation and Public Enlightenment, COPE, a non-governmental organisation located in Adeniyi Jones, Lagos. Handing over the screening machines to Ebun Anozie, national coordinator, COPE, Kehinde Durosinmi-Etti, group…
New Wonder Drug against Cancer
T-DM1, a cancer drug, has emerged a game changer in breast cancer treatment. Last week, doctors in the United States, pronounced T-DM1, a drug to watch in preventing fatalities among women with very advanced breast cancer. If this drug sails through further scrutiny, it will be available in one year and rubbish the five-year…